These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2172621)

  • 21. Immunological status and pathology of coxsackie B viral myocarditis and dilated cardiomyopathy.
    Chen SX; Mei SW; Bao SH; Zheng XJ; Chang PL; Yao JS; Yao S; Zhang DQ
    Chin Med J (Engl); 1993 Sep; 106(9):659-64. PubMed ID: 8287699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of Coxsackie B viruses in the etiology of dilated cardiomyopathy].
    Shirobokov VP; Amosova EN; Korniushenko ON; Evtushenko AI; Krivolap VI
    Ter Arkh; 1990; 62(3):107-10. PubMed ID: 2164261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
    G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxsackie B4 viral myocarditis causing ventricular aneurysm.
    Goudevenos J; Parry G; Gold RG
    Int J Cardiol; 1990 Apr; 27(1):122-4. PubMed ID: 2159445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.
    Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Virus and dilated cardiomyopathies].
    Bouhour JB; Langlard JM; Kopecka H; Petitjean J; Freymuth F
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():15-20. PubMed ID: 8215785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy.
    Schwimmbeck PL; Badorff C; Rohn G; Schulze K; Schultheiss HP
    Int J Cardiol; 1996 May; 54(2):117-25. PubMed ID: 8803675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy.
    Huber SA; Budd RC; Rossner K; Newell MK
    Ann N Y Acad Sci; 1999; 887():181-90. PubMed ID: 10668474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocarditis and dilated cardiomyopathy: different stages of the same disease?
    Fallon JT
    Cardiovasc Clin; 1988; 18(2):155-62. PubMed ID: 2820574
    [No Abstract]   [Full Text] [Related]  

  • 30. [Etiological association of Coxsackie B viruses with idiopathic dilated cardiomyopathy].
    Yang LD
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Jun; 12(2):86-9. PubMed ID: 6092027
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiac myosin-induced myocarditis as a model of postinfectious autoimmunity.
    Neu N; Klieber R; Frühwirth M; Berger P
    Eur Heart J; 1991 Aug; 12 Suppl D():117-20. PubMed ID: 1655442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis.
    Latva-Hirvelä J; Kytö V; Saraste A; Eriksson S; Vuorinen T; Pettersson K; Saukko P
    Eur J Clin Invest; 2009 Jun; 39(6):457-62. PubMed ID: 19397694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis.
    Lane JR; Neumann DA; Lafond-Walker A; Herskowitz A; Rose NR
    J Immunol; 1993 Aug; 151(3):1682-90. PubMed ID: 8335952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis.
    Spotnitz MD; Lesch M
    Prog Cardiovasc Dis; 2006; 49(1):42-57. PubMed ID: 16867849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The expression of coxsackie B virus adenovirus receptor (CAR) in viral myocarditis and dilated cardiomyopathy patients].
    Li HY; Li YH; Zhu TJ
    Fa Yi Xue Za Zhi; 2007 Aug; 23(4):247-9. PubMed ID: 17896511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological characteristics of viral myocarditis].
    Kipshidze NN; Chumburidze VB; Demetrashvili MF; Dzidziguri LM
    Ter Arkh; 1988; 60(4):136-9. PubMed ID: 2839908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
    Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
    Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases.
    Sauter P; Hober D
    Microbes Infect; 2009 Apr; 11(4):443-51. PubMed ID: 19399964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.